UC-961
Drug
Celgene Corporation
Total Payments
$116,667
Transactions
1
Doctors
0
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2017 | $116,667 | 1 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $116,667 | 1 | 100.0% |
Top Doctors Receiving Payments for UC-961
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | La Jolla, CA | $116,667 | 1 |
Ad
Manufacturing Companies
- Celgene Corporation $116,667
Product Information
- Type Drug
- Total Payments $116,667
- Total Doctors 0
- Transactions 1
About UC-961
UC-961 is a drug associated with $116,667 in payments to 0 healthcare providers, recorded across 1 transactions in the CMS Open Payments database. The primary manufacturer is Celgene Corporation.
Payment data is available from 2017 to 2017. In 2017, $116,667 was paid across 1 transactions to 0 doctors.
The most common payment nature for UC-961 is "Unspecified" ($116,667, 100.0% of total).